Review
Jul 2026
Advances in FGFR Inhibition for Bladder Cancer: A Review of Molecular Targets and Therapeutic Progress
This review underscores the transformative potential of molecular profiling and FGFR-targeted therapies in the evolving management of bladder cancer, with special attention given to the fibroblast growth factor receptor (FGFR) signaling pathway.
Nandita Yadav, Nihar Ranjan Sarmah, Ketan J. Purohit et al.
· Current Pharmacogenomics and... · 0 citations